US FDA cites Bayer for Yaz TV commercial violations

Two television commercials for[C#198600358:Bayer] Healthcare's Yaz (drospirenone plus ethinylestradiol) broaden the oral contraceptive’s indication, overstate its efficacy and minimise risks, the US FDAhas said in a warning letter.